REGISTERED COMPANY NUMBER: 02361986 (England and Wales)
REGISTERED CHARITY NUMBER: 801279
REPORT OF THE TRUSTEES AND
FINANCIAL STATEMEwfs FOR THE YEAR ENDED 31 DECEMBER 21)23
FOR
THE MYALGIC ENCEPHALOPA THY ASSOCIA TION LIMITED
Astral Accountancy Scrvicc5 Limitcd
2B Marston House
Cromwell Business Park
Chipping Norton
Oxford%hire
OX7 5SR

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
CONTENTS OF THE FINANCIAL STATEMENIS
FOR THE YEAR ENDED 31 DECEMBER 2023
Page
Report of the TTh￿teeS
Report of the Independent Auditors
9 10
Statement of Financial Activities
12
Balance Sheet
13
C&5h Flow Statement
14
Notes to the Cash Flow Slalement
15
Notes to the Financial Statements
16 10 28
Detailed Statement of Financial Activities
29 10 30

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
REPORT OF THE TRUSTEE5
FOR THE YEAR ENDED 31 DECENIBER 21)23
The trustees who are also directors of the charity for the purposes of the Companies Act 2(K)6. present iheir report with the financial
staiements of the charity for the year ended 31 December 20?3. The rrustees have adopted the provisions of Accounting and Reporting
by Charities.. Statement ot Recommended Practice applicable lo charities preparing their accounts in accordance with the Financial
Reporting Standard applicablc in thc UK and Republic of Ircland IFRS 102) (cffcctivc l January 2019).
Page I

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
REPORT OF THE TRUSTEE5
FOR THE YEAR ENDED 31 DECENIBER 21)23
OBJECTIVES AND ACTIVITIES
Charitable Objectives
The charity is established to offer relief to persons of all ages with Myalgic Encephalopathy (M.E.)IChronic Fatigue Syndrome (CFS)
through the provision of Info￿natiOn. to further education in all aspects of the illness. and to 5UPIX)rt research and to publish the usetul
results.
What we do and wh
wcdoit
M.E. Imyalgic encephalopathy or encephalomyelilis) is a ¢omplex muliisysiem disease with a wide range of disabling .gympiom8. The
ME A%sociation is here 10 support people ihrough all Svages of their illness because we desperatrly want ¢0 see everyone get ihe help
Ihey need and, through research, help to develop an effeciive rreatmeni and one day even a cure.
We don'i employ an expensive ￿0. Instead we have an ierrific group of trllsiees who provide straiegy and management on a voluniary
basis. Trustees are supponed by an eX￿rienced ieam of full and part lime staff who are committed (o sup]N)rting the M.E. community.
We also have a large number of dedicated volunteers who help ensure ME Connect - the tele
needing support or inforniation.
hone hel line - is available for people
Our main priorities are to provide suppor¢ reliable inforniation, a voice and representation, and funding for ￿tal medical
research.
for
sitive chan
Trusrees al￿nd and rep)rt on the iMporL￿[ external conferences and meetings th￿ take place.
We are active members of Forward ME which is an influeniial adV(￿aCY group comprising chariry and political representatives. We
also coniribute to the CFSIME Research CollalK)raiive {CMRC) which is made up of scieniists. clinicians and adv(Kates.
The Ramqa
Research Fund
The ME Associaiion funds research through ihe Ramsay Research Fund (RRF) which was named after Dr Melvin Ramsay who helped
bring awarcncss ot M.E. to the mcdical profcssion in 1955.
Dr Ramsay also helped establish the ME Ass(Kiation and was its prcsident for a number of year5. He remained closcly involved with
the Ch￿tY until hi5 death in 1990.
We spend a lot of our titne and cffort working with scicntists on new rcscarch grants bccausc funding good quality biomedical research
is a key prioriiy for ihis Lhariiy.
ort when it's needed
We pui a loi of resource inio giving as much support io people affectrd by this dise&se as we can. We do thi.g by answering cries for
help and providing exiensive infonnaiion. through phone calls ￿ head office. emails or messages via social media or ME Connect - the
ielephone helpline.
We have around 5,(XK) paid-up members who receive our quarterly magazine ME Esseniial. We receive funds and qup]x)rt from
members and an increasing number of non-members. Support for the ME ASs(￿laU0￿ continues 10 grow. mosi often by non-tradiiional
methods c.g. social Tncdia.
Website and Social Media
Page 2

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
REPORT OF THE TRUSTEE5
FOR THE YEAR ENDED 31 DECENIBER 21)23
The ME A.9s(￿laI1on'S websiie and social media plarf0rn￿ coniinue to a￿racI sirong numbers of visiiors wilh reach and engagement
rates showing we are being effective.
Public benefit
In preparing these financial stateTnents and their retK>rL ihc Trustce5 confirm that they have had regard to the Charity Commission's
guidance on public benetit. and that they consider the objectivcs and activitics of ihc charity have historically and continue to fall
within the Scot￿ of that guidance.
Page 3

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
REPORT OF THE TRUSTEE5
FOR THE YEAR ENDED 31 DECENIBER 21)23
STRA TEC.IC REPORT
Achievement and performance
Charitable Activitie5
2023 has been a ycar of changc at thc ME Association. Change within our staff and our Board of Trustees. This year Tony Britton, our
tundraising manager. stepped down into a part tiTnc role after 20 years with us. A new full-time fundraiscr has becn appointed. Hi1￿Y
Briars, our ME Connect Manager, is lea￿'ing us to spcnd hcr retirement doing thosc things shc has nei'er had time to do before. I shall
mis5 hcr calm logic and the wonderful friendly voice. In placc of our rctiring truslcc5, Nicola Anson and Rick Osinan, wc welcomed
Georgina Evans and Michacl Mitchell a5 associatcs. With Rick 05man, our Vicc-chairman, leaving the Board, David Allen was
unanimously appoinied to ￿ke up that role.
Our chariiable work in the pasi year has been exten.sive and productive. Ils core objeciives. 10 inform, suppon and fund reqearch,
continue to drive us. With leafieis and bookleis on almos( every &speci of the illness. including the practical aqpecis of living with i(, we
have helped thousands of people io deal wilh MEJCFS. One of the resulLS of the Covid virus haq been Ihat many now Suffering from
Long Covid have come 10 our webqite for infonnaiion on the sympioms we share with Ihai illness. Our webqite and qocial media
enabled us to reach people throughout the UK and abroad. We keep pace with the latesi deiTelopments in managemenL diagnosis and
treatment ihrough our social media news broadcasts and e -newsletters. We have a substantial presence on social media w'ith a first-
class team answering enquiries and engaging with everyone who has affected by MFJCFS and Long Covid.
Our support for people with MEICFS comes through our telephone helpline. ME Connect. our email answering service and our social
media channels. ME Connect is a professionally managed information and SUPFK)rt service unique amongsi MEICFS charities. With an
all-year-round service, our highly trained i'olunteers empathetically li%ien io heartbreaking %¢ories of people devasth(ed by this illness.
Their role also includes signpo.sting callers 10 oiher agen¢ie¥ where help may be ai'ailable for them. This year, Long Covid 4ufferers,
wilh similar symptoms 10 MEICFS. coniinued io swell numkrs conLq¢iing ME ConnecL
Campaigning has always been a core part of our charity's work and we are fortunaie io have amongsi our (rusiees a Consummaie
professional in this field. Martine Ainsworth-wells has led our Communicaiions Team in driving aiiention to issues that face ail of us
with this illness.
Thiq year we ran our biggesi ever survey called "Couni ME In" which allrncied over 7.2(M) responses. The aim was to capture ihe
experiences of those people living with MEJCFS and Long Covid and use these results to be more effective in irying to improve health
and social care in the monihs and years ahead. The campaion behind this resulied in 2,746.672 people seeing or listening to lis
promotions. The results of the suryey will be analy5cd by an indepcndent rcscarch team and wc will publish their full report in 2024.
Our research funding continued throughout the year. The charity continued to fund thc baslc running costs of thc UK MEICFS Bio-
Bank at the London School of Hygienc and Tropical Mcdicinc. Wc have rccently agreed a further Iwo-year tunding of this most
valuable resource. Demand from researchcr5 for its blo(NJ samplcs has steadily increascd. Oihcr research funding has bccn provided at
Leice5tcr University, Oxford University, Lii'erpool. and Surrcy Univcrsities. Wc have also cnlcred a new collaboration with the
Man¢he%rer Brain Bank io carry out posimortem research.
The NICE Guideline for MFJCFS Still involve% the charily in much work. Some ho%pitsl Iru%LS are Siill offering management of ihe
illnes8 based on GET (graded exercise therapy) and CBT (cogniiive behaviour therapy) Our Medical Advisor, Dr Charles Shepherd,
wrote io many healih b(xJies during the year requiring them io updaie iheir advice and infomiation aix)ut MEICFS and achieved much
succeqs. Our charity coniinue$ 10 moniior the implemeniaiion of the Guidance across health and care proiTiderq. We have also been
heavily involved in the Departhieni of Health and SOCI￿ Care consuliaiion on the fllTh￿e of servlces for MFJCFS paiienis.
Fonvard ME is an 'umbrella' groupino of several MFJCFS organisations including the ME Associaiion. We make a subsiantial
contribution lo its know'ledge base. especially on the medical side.
Page 4

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
REPORT OF THE TRUSTEE5
FOR THE YEAR ENDED 31 DECENIBER 21)23
The chariiy's membership has held sieady despiie the Ch￿lengIng economie ouilook. I am very grnteful to all our members for
continuing their support and enabling us to continue our work. The ME Association has always adopied a cautious approach to its
funding and lis Audit, Risk and Ini'esiment con]mittee meets every two months to review our income and expendiiure and budget for
the future.
In the past year we have continued the stratcgic rcvicw of the charity's corc objective5. We have identified who, about what and how
wc need to SUPPOrt people with MFJCFS. Similar reviews havc lookcd at finding diagnostic markers. causes and treatments together
with our remits to educatc and influcncc. Wc arc now moving forward to implcmcnt the stratcgy.
Our quarterly magazine for members, ME Essential, is our main resource in keeping our members infornied aboui wha¢ we are doing.
We al80 mail out our Medical Magazine 10 many medical professionals. containing more details of receni research findlngs in the field
of MEICFS.
Donaiions, appeals and legacies have shown how well our chariry is reoarded amongsi paiienis. We are overwhelmed at their
generosity and their efforis to raise money through an amazing variety of events. The generosity and ingenuity that our members show
in raising money for the charity is deeply moving. We are very graieful for all their help.
Our staff have worked tirelessly throughout the year to enable the charity to continue with its work and the trustees wish to thank them
for their dedication and sheer hard graft. I would also like to thank our trustees for giving so much of their time. Several have MEICFS.
look after someone who has it or lead demanding working lives. With them. this charity has prospered. Without them. it would be lost.
The coming year will be iesting bui our work for you will noi slow down. New campaigns are being prepared- research opportunilies
examined. I believe iha¢ the perception of our illness is undergoing a change. The me%sage ihat MEICFS is a real. physical illnes.9 is
beginning io reach those parts of Ihe medical world which had previously iurned a deaf ear ￿WardS it.
Financial review
Financial position
The ME Association saw iotal funds increase by £264.235 10 £3.608.810 in 2023.
The Charity saw income rise by £157,324 compared with the previous year. We saw increases in donations and legacies as well as
investment income due (o favourable in(eresi raies.
Annual membership subscripiions make up a small bui significant contribution towards the operaiinu costs of the charity with the
ditference being madc up through donations. Membership subscription income dccrcascd slightly in 2023 but is still higher than pre-
pandemic Icvcls.
Legacy inconic remaincd at a similar level 10 202? with the charity rccciNing Icgacics of £509,340 in thc ycar (£490,613 in 20221. Gifts
from lega¢ies conrinue io be an importan¢ source of income for the ¢harily. and we are very gra￿ful to ihose who consider us.
Unle85 any donation, legacy or fundraising income is expres%ly restrictrd 10 the PUryK)se of funding re9ear¢h activilies, all income is
allocated to general funds. Gener&1 fund.s can be and have ￿en applied 10 fund research in addiiion 10 reqiricied fi]nds.
Overall expenditure of the chariiy increased by £122.208 compared with the prior year. with additional funds being used on our biggest
ever survey 'Count me in. and increased siaff cosis.
The Audii, Invesimeni and Risk Committee mei reoularly during the year 10 supwrt the Board by closely monitoring how we qpend
and safeguard ihe charity's assets, improve Governance. srrengthen internal controls. and manage risk. This will support the Board in
fulfilling it5 dutlcs and planning tor the future of thc chatily.
Page 5

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
REPORT OF THE TRUSTEE5
FOR THE YEAR ENDED 31 DECENIBER 21)23
STRA TEGIC REPORT
Financial review
Reserves
Total funds stood at £3,608.810 at 31 DcceTnbcr 2023
The ME Association has set aside5 dcsignated rcservcs to support the continucd (klivcry of its core services for the next 12 months
from annual meTnber5hip subscription which aTtKTrunt to £49).500. We also havc set up a sinking fund to prcparc for any futurc rcpair
costs to ihe building should they arise.
Free reserve8 at 31 December 2023 were £2.222.674 (2022= £2.496.603). Free reserves are calculated as unresrricted reserves, less
designaied reserves. less the nei book N'alue of fixed assets.
The Trusiees aim io hold 12 months of operaiing cosis in reseryes io deliver on membership fees paid in advance. The Trustee8 are alqo
mindful of cotnmitted future costs for ihe Biobank and poteniial pressures on costs. Greater awareness of post-viral faiigue. arising
frotn the prevalence of Long Covid, has increased the demand for high qualiiy and urgeni research inio these diseases. The Trusiees
anticipate that there will more and n]uch larger research projects to be funded or cfrfunded going forward and have been accumulating
reserves to supplement restricted funds in anticipation.
The MEA holds separate funds restricted in purpose for financing research into as[￿C[S of Ihe cause of and development of treatment of
(he disease. The charily re¢ognise% its duty to hold reserves of restricted funds io meei &¢crued Commiimenis 10 fund re%earch projecis,
or ro hold such reseives in both restricied and Un￿s￿l¢le￿ funds. in ￿ditiOn io lis exisiing obligaiions for holding unre.siri¢ted reserves.
Resiricted reserves cannoi be used for purposes other than the objectives of supporting and publishing research. In the eveni of ihe
cc)mpany winding up, the ix)ard has the responsibility of disbursing the balance of any restricted funds io a UK charithble fund with
purpose8 closesi 10 the objective of supporting and publishing research into Myalgic Encephalopathy.
Free Reserves
Free reqerves at the end of 2023 were £2,222.674 (2022= £2.496.6A)3).
Unrestricted funds
Unrcstrictcd funds have increased by £211,654 in 2023.
Unrcstrictcd funds at 31 December 2023 amountcd to £2.830.928 in 2023 (2022.. £2.619,274).
Restricted tunds
Restricted tunds relate to our ￿searCh programme named thc Ramsay Research fiTnd and increascd by £52.581.
Restricted funds at 31 December 2023 amounied 10 £777.882 (2022= £725.3011.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The charity is esiablished under a Memorandum of Association which esthblished the objecrs and powers of the charitable company
and is governed by lis Articles of Association.
Page 6

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
REPORT OF THE TRUSTEE5
FOR THE YEAR ENDED 31 DECENIBER 21)23
STRUCTURE, GOVERNANCE AND MANAGEMENT
Charity constitution
The charity constitutes a limited company. limited by guarantcc, as dcfincd by thc Companic5 Act 2(K)6.
Mcmbcrshi
Mcmbers subscribc annually and voting right5 arc ba5cd on thc cutrency of thcir subscription. Members of the charitable company
guarantee to contribute an amount not cxcccding £1 to the assets of thc charitablc company in the cvent of winding up.
Recruitment and ap￿IntMent of new tn￿leeS
The charity is managed by elecied rrusiees. The Articles of Associaiion require thai one third of Ihe rn]siees re(ire every Iwo years but
remain eligible for re-eleciion. Trustees are elecied by the members of Ihe chariiy and musi comprise of people wlth an inierest in
MEICFS.
Applications to become a ttwstee are advertised in both the quarterly magazine of the charity and its social network media. Reference is
made that applications are welcome from all and to ethnic diversiry. There is a limit of eight trustees but the Board can co-opt up to
three additional members at any time. Co-opted trustees are then put forward to the membership for election at the next annual general
meeting {AGM) at which elecllons will take place.
Voting takes place by either postal ballot or at the AGM.
REFERENCE AND ADMINISTRATIVE DETAtts
Registered Company number
02.361986 (England and Wales)
Registered Charity number
801279
Registered oftfice
Unit 7 Apollo Office Court
Radclive Road
Gawcott
Buckingham
Buckinghamshirc
MKI8 4DF
Trust(*s
Mis% M Ainsworth-wells
Mrq N Anson (resigned 31.5.23)
MrESDale
Mr R W Osman (resigned 7.1.23)
Mr N H Riley
Dr C B Shepherd
Mr D A Allen (appointed 20.2.23)
Page 7

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMtTED
REPORT OF THE TRUSTEE5
FOR THE YEAR ENDED 31 DECENIBER 21)23
REFERENCE AL¥D ADMINISTRATIVE DETAIiS
Auditor5
Astral Accountancy Scryiccs Limited
2B M￿st0￿ Housc
Cromwell Business Park
Chipping Norton
Oxford5hire
OX7 5SR
STATEMENT OF TRUSTEE.S' RLSPON.SIBILITIES
The trusiees (who are also the direc(ors of The M)'aigic Encephalopathy Association Limiied for the purposes of company law) are
responsible for preparing Ihe Report of the Trustees and the financial staiemenis in accordance with applicable law and Uniied
Kingdom Accouniing Siandards (Uniied Kinodom Generally Accepted Accollniing Practice) including Financial Reporting Standard
102 The Financial Reponing Standard applicable in the UK and Republic of Ireland"
Company law requires the irustees to prepare financial siatements for each financial year which give a trne and fair view of the state of
affairs of the charitable company and of ihe incotnino resources and application of resources. including the incorne and expenditure. of
the charitable company for that period. In preparing ihose financial staremenis. the rrustees are required to
selecr suirable accouniing policieq and ihen apply ihem ¢onsistrntly-
observe the meihod% and principles in the Charity SORP-
make judgemenis and esiimaies thai are re&wnable and prudent:
srate wheiher applicable a¢couniing siandards have been followed. subject to any ma(eria] departures disclosed and explained in ihe
financial .statemenLS;
prepare ihe financial staiemenis on the going concern basis unless li is inappropriaie to presume that the charitable company will
continue in business.
The trustees are reswnsible for keeping proper accouniing records which disclose with reasonable accurncy ai any lime the financia]
position of the charitable company and to enable them to ensure Ihat ihe financial statements comply wilh the Companies Act 2006.
They are also responsible for ￿egllardlng the assers of the chariiable company and hence for taking r&qsonable sieps for the preveniion
and detection ot traud and other irrcgularities.
In so far as the trustecs are awarc..
there is no relevant audit intortnation of which ihe charitablc company's auditor5 arc unaware- and
the trustees have taken all steps that thcy ought to have takcn lo makc thcmsclvcs aware of any relevant audit information and to
establish ihai the auditois are aware of that inforn)aiion.
AUDITORS
The auditor8. Astral Accouniancy Services Limited. will be prowsed for re-appointmeni ai the forthcoming Annual Genernl Meeting.
stees, incorporaiing a straiegic rew)rt, approved by order of the tN)ard of trustees, as the company directors, on
. and signed on the board's behalf by:
Mr N I l Riliv -'I'ru,%lL
Page 8

REPORT OF THE INDEPENDENT AUDrtOlLS TO THE ￿￿mBERs OF
THE ￿lYALGIc ENCEPHALOPA THY ASSOCIA TION LINIITED
Opinion
We have audited the financial statements of The Myalgic Encephalopathy AsS￿latiOn Limited (the 'charitable company,) for the year
ended 31 December 2023 which comprise (he Siaiement of Financial Activities. the Balance Sheei, the Cash Flow Siatemeni and notes
to the financial statements, including a summary of significant accounting policies. The financial reportinu fratnework that has been
applied in their preparation is applicable law and Uniied Kingdom Accouniing Standards (United Kingdom Generally Accepted
Accounting Practice). including Financial Rcporting Standard 102 Financial Reporting Standard applicablc in the UK and
Republic of Ireland,.
In our opinion the financial statements..
give a truc and fair view of the statc of the charilablc coJnpany's affai￿ as at 31 DccemlKr 2023 and of its incoming resources and
appli¢aiion of resources, including its income and expendiiure. for Ihe year ihen ended-
have been prO[￿rIY prepared in ac¢ordan¢e wilh United Kingdom Generally A¢¢ep¢ed Accouniing Praciice, including Financia]
Reporting Standard 102 The Financi&l Reponing Siandard applicable in the UK and Republic of Ireland.: and
have been prepared in accordance with the requirements of the Companies Aci 2(M)6.
Basis for opinion
We conducied our audit in accordance with International Standards on Auditing {UK} (ISAS (UKI) and applicable law. Our
responsibilities under those standards are further described in the Auditors, responsibilities for the audit of the financial statements
section of our report. We are independent of the chariiable company in accordance with the ethical requirements that are relevant to
our audit of the financial statements in the UK. including the FRC'S Ethical Standard. and we have fulfilled our other ethical
responsibilities in accordance wilh these requirements. We believe thai the audit evidence we have obtained is sufficient and
appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial sta¢emenis, we have concluded th￿ the irustees, use of the going concern basis of a¢coun¢ing in the preparaiion
of the financial siaiements is appropriatr.
Based on the work we have perfonned. we have noi ideniified any maierial uncenainiies relating io events or conditions thai,
individually or colleciively. may cL%i significani doubi on the chariiable company's abiliry 10 continue as a going concern for a peri(Ml
of at leasi Iwelve months from when Ihe financial statemenis are authorised for issue.
Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this
report.
Other information
The trustees are responsiblc for the other informatiovt. The othcr inforJnation COTnprises the information included in the Annual Report
other than the tinancial statements and our Report of the Indcpcndcnt Auditors thercon.
Our opinion on thc financial statements docs not cover ihc other information and. cxccpt to the cxtcnt otherwise explicitly stated in our
report. we do noi expre%s any fom) of &ssuran¢e con¢lu%ion thereon.
In ¢onne¢iion wilh our audit of ihe financial SLq¢emenis. our respon%ibility 1$ 10 read the oiher infornjaiion and. in doing $0, consider
wheiher ihe other informaiion is maieriaily inconsisieni wilh ihe financial siaiements or our knowledge obiained in the audii or
otherwi.se appears 10 be materially missu¢ed. If we identify such maierial in¢onsi%ienLies or appareni miierial missiaEmen¢q, we are
required to deiermine whether Ihis gives rise 10 a maieriai missiaiemeni in ihe financial staiemenis themselves. If, based on ihe work
e have perfonned, we conclude thai Ihere is a maieriai misstaiemeni of this other infonnation. we are required io rew)rt that faci. We
have nothing to report in this tEgard.
Opinion5 on other matters prescribed by the Companie5 Act 21M16
In our opinion. based on the work undertaken in the course of the audit=
the intormation given in the Report of the TrustCC5 for the financial ycar for which the financial statements are prepared is
consistent wilh the finan¢i&l staiemenis- and
the Report of the Trustees has been picpared in accordallcc with applicable Icgal rcquirements.
Page 9

REPORT OF THE INDEPENDENT AUDrtOlLS TO THE ￿￿mBERs OF
THE ￿lYALGIc ENCEPHALOPA THY ASSOCIA TION LINIITED
Matters on which we are required to report by exception
In the lighi of the knowledge and undersianding of the chariiable company and irs environmeni obtained in Ihe course of the audii, we
have not identified material misstatemenis in the Re￿rt of the Trusiees.
We have nothing to rcport in rcspect of thc following matters where the CoTnpanic5 Act 2(A)6 requires US to report to you if, in our
opinion..
adequate accounting records have not bccn kcpt or rcturn5 adcquatc for our audit havc not been received froTn branches not visited
by us,. or
the tinancial statCTnents arc not in agreement with the accounting rccords and rcturns- or
certhin disclosures of trustees, remuneraiion specified by law are not made: or
we have not received all ihe infomation and explanaiions we require for our audil.
Responsibilities of trustees
As explained more fully in the Siaiemeni of Trusiees. Responsibiliiies. the rrusiees (who are also the directors of Ihe charitable
company for the purp)%es of company law} are res￿nsIble for the preparaiion of the financial siaiements and for being satisfied that
they give a true and fair view, and for such internal control as the trustees detertnine is necessary to enable the preparation of financial
statements that are free from material missiatement. wheiher due to fraud or error.
In preparing the financial statements, the trustees are reswnsible for assessing the charitable company's ability to continue as a going
concern. disclosing, as applicable. matters related to going concern and using ihe going concern basis of accouniing unless the trustees
either intend to liquidate the charitable company or to cease operntions. or have no realistic alternative but to do so.
Our responsibilities for the audit of the financial staiements
Our objectives are io obiain reasonible assurance aboui whether the financial sthiemenLS as a whole are free from maierial
misstatemeni. wheiher due to fraud or error, and io issue a Report of the Independeni Audiior.s ihai includes our opinion. Re&sonable
assurance is a high level of assurance, bui ]% noi & guaraniee thai an audit ¢onducied in acLx)rdance with ISAS IUKI will always deteci a
material mi8siatemeni when it exisis. Missiaiemenis can arise from fraud or error and are considered maieriai if, individually or in the
agoregate, they could reasonably be expected (o influence the economic decisions of users taken on the basis of these financial
staiemenis.
A further description of our responsibilities for the audit of the financial statemenis is located on the Financial Reporting Council's
website at www.frc.org.uklaudiiorsresponsibilAties. This description fonns part of our Repon of the Independeni Audiiors.
Pagc 10

REPORT OF THE INDEPENDENT AUDrtOlLS TO THE MEMBERS OF
THE ￿lYALGIc ENCEPHALOPA THY ASSOCIA TION LINIITED
Use ot our report
Thi8 repori is made solely to the chariiable company's members. as a b￿y. in accordance with Chapter 3 of Part 16 of Ihe Companies
Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are
required to state to thetn in an auditors. report and for no oiher purpose. To the fullesi exteni periniited by law, we do not accept or
assume responsibility to anyonc other than the charilablc covnpany and the charitable COTnpany's members as a body, for our audit
work, for this report, or for thc opinions we have fortncd.
•Jt4
Tracy Norris (Scnior Statutory Auditor)
fc)r and on behalf of Astral Ac¢ounthncy Services Limited
2B Marsic)n House
Cromwell Business Park
Chipping Norton
Oxfordqhire
OX7 5SR
6 Sep(ember 2024
Pagcll

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
STATE￿]ENT OF FINANCIAL ACTIVITIFS
FOR THE YEAR ENDED 31 DECENIBER 21)23
2023
Total
fund5
2022
Toial
funds
Unrestricted
funds
Restricted
fund
Notc5
INCONIE AND ENDOWMENTS FROM
Dondtions and Icgacies
643078
181,454
825,332
718,791
Charitable activities
Inforniaiion and Support
Other trading aciivilies
Investment income
88,742
54,131
40059
88,742
54,131
49,640
3.5,943
12,735
8,781
Total
827.610
190
1017 845
860,520
EXPENDITURE ON
Charitable activities
Fundraising Expense5
Inforniaiion Ind Support
9884
606,072
9,884
743,726
137,654
631,401
Total
615 956
753 610
631,401
NET INCOME
211,654
52581
264235
229,119
RECONCILIATION OF FUNDS
Total funds brought forward
2,619274
725J)I
3J44575
3,115,456
TOTAL FUNDS CARRIED FORWARD
2,830,928
777,882
3,608,810
3,344,575
The notes form part of these fjnancial slaiements
Pagc 12

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMtTED
BALANCE SHEET
31 DECEMBER 2023
2023
Total
fund5
2022
Toial
funds
Unrestricted
funds
Restricted
fund
Notc5
FIXED ASSETS
Tangible as5et5
14
112,754
112,754
122,671
CURRENT ASSETS
Siocks
Debtors
Inve8iments
Cash a( bank and in hand
15
16
17
8571
403520
lJ91,916
969,974
8571
403,520
2,006,445
1,195,084
10,986
806,091
1,061,717
1,440,555
614,i29
225,110
2,773,981
839,639
3,613,620
3,319,349
CREDITORS
Amounts falling due wiihin one year
18
(55J107)
161,757)
(117564}
197,4451
NET CURRENT ASSETS
2.718.174
3 496 056
3,221,904
TOTAL ASSETS LESS CURRENT LIABILrriLs
2*30,928
777,882
3,608,810
3.344,575
NET ASSETS
2*30,928
777,882
3,608,810
3.344,575
FUND.S
Unresiricted funds
Restricted funds
19
2030,928
777,882
2,619,274
725,301
TOTAL FUNDS
3,608,810
3,344,575
19.08.2024
The financial .qtatements were approved by the Board of Trnsiees and authorised for issue on ............................................. and were
signed on ILS behalf by..
Mi N H Rili)'_ TtUS
The notes form part of these financial statements
Page 13

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
CASH FLOW STA TETrIENr
FOR THE YEAR ENDED 31 DECEMBER 21)23
2023
2022
Notes
Cash floivs from operating activities
Cash generated trom operations
Interest paid
655.￿3
14,1961
589,455
4,493)
Nei cash provided by operating activities
651707
584,962
Cash flows from investing activities
Purchase of tangible fixed asseis
(Increase) l Decre&8e in Tenn Deposiis
Interest received
(2,0901
(944,728)
49,640
{5,718)
{565,242)
12.735
Nei cash used in investing aciivilies
1897,178)
1558,2251
Change in cash and cash equivalent5 in the
reporting period
Cash and cash equivalents at the beginning of
the reporting period
(245871)
26.737
1,413,818
Cash and cash equivalents at the end of the
reporting period
1,195,084
1.440,555
The notes form part of these fjnancial slaiements
Pagc 14

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECENIBER 21)23
RECONCILIATION OF NET INCOME TO NET CASH FLOW FROM OPERATING AcTIv￿IEs
2023
2022
Net income for the reporting period las per the Statemen¢ of Financial
Actii'ities)
Adjustments for:
tkpreciation charges
Interest received
In￿re$r paid
De¢re&8el{increasel in siocks
Decrease in debiors
Increasel(decrease) in creditors
264235
229,119
12,0(K)
149,640)
4,196
2,415
402571
20,120
11,434
(12,735)
4,493
117.3)
386,234
128,917)
Net cash provided by operations
655,W3
589,4.55
ANALYSIS OF CHANGES tN NET FUNDS
At 1.1.23
Cash flow
At 31.12.23
Net cash
Cash at bank and in hand
IA40555
(245,471)
1,195,084
1,440555
(245,471)
1,195,084
Liquid re50urce5
tkp05it5 included in cash
Curreni assei invesimenis
1,061,717
944,728
2,006,445
1,061,717
944,728
2,006,445
Total
2502272
699,257
3201,529
The notes form part of these fjnancial slaiements
Pagc 15

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENT5
FOR THE YEAR ENDED 31 DECENIBER 21)23
ACCOUNTING POLlCtES
Basis of preparing the financial statements
The tinancial statements of the charitable company. which 15 a public bcncfit cnlity under FRS 102, have been prepared in
accordancc with the Charitles SORP (FRS 102) 'Accounting and Rcporting by Charities.. Statement of Recommcnded Practice
applicable to charities prcpating their accounts in accordance with the Financial Reporting Standard applicablc in the UK and
Republic of Ireland IFRS 102) (effectivc l January 2019).. Financial Rcwjrting Standard 102 'The Financial Reporting
Standard applicable in the UK and Republic of Ireland. and thc Companies Act 2(K)6. The financial statements have been
prepared under the historiLal cosi coni'eniion.
The Myalgic Encephalopathy Associaiion meeis the defini(ion of a public benefii eniiiy under FRS 102. AsqeL8 and liabilities
are iniiially recognised at hisiorical cosi or transacilon value unless othenvise stsied in the relevani accounting policy.
Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds. it is probable
that the income will be received and the amouni can be measured reliably.
For legacies. entitletnent is taken as the earlier of the dale on which either: the company is aware that the probate has been
granted, the estaie has been finalised and notification has been made by the executor{sl to the Trust that a distribution will be
made, or when a distribuiion is received from the estaie. Receipt of a legacy. in whole or in part. is only considered probable
when ihe amouni can be me&sured reliably and the company has been noiified io Ihe exe¢uior'% inteniion to make a
disrribuiion. Where legacies have been noiified ￿ the company. or Ihe company i% aware of ihe granting of probaie, and (he
criieria for income recognilion have noi been mei. then the legacy is ￿ated as a coniingent as.gei and disclosed if maierial.
Gifis in kind donated for disiribuiion a￿ included at valU￿10n and recognised as income when they are digiributed io ihe
projects. Gif(s donaied for resale are included as income when they are sold. Donaied faciliiies are included at ihe value to the
company where Ihis can be quaniified and a third parry is bearing the cosi. No amounts are included in the financial statements
for services donaied by volunieers.
Donated services of facilities are recognised w'hen the company has conwol over the item. any conditions associated with the
donated iiem have been mei, the receipt of economic benefii from the use of the company of Ihe iiem is probable and that
cconomic ￿nefit can be me&suied reliably. In accordance with Charities SORP (FRS 1021. the general voluntcer time of the
Friends is not recognised and refer to the Trustees, report for more information about their contribution.
On rcccipt, donated professional sctViCC5 and donatcd facilitlC5 arc rccogniscd on the basis of the value of the gift to the
company which is the amount thc COTnpany would havc bccn willing io pay to obtain scrviccs or facilitses of equivalcnt
cconomic benefit on thc opcn markct- a co￿eSPOndIng avnount is then recogniscd in expcnditurc in the period of receipt.
Other income is recognised in the ￿ni)d in which li is recovernble and io the exieni the g(M)ds have been provided or on
compleiion of Ihe service.
Expenditure
Liabiliiies are recognised as eXpendIn￿e as soon as there is a leoal or constsuciive obligation commiiting the charity (o that
expenditure. li is pmbable thai a transfer of economic benefiis will be required in settlemeni and the amouni of the obligation
can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that
agoregate all cost relaied io ihe caiegory. Where cosrs cannoi be directly attribuied io panicular headings Ihey have been
allocated to actAvities on a basis consistent with the use of resources.
Rcsourccs are expendcd in the furtherance of the charity's objcctive5.
Page 16
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
ACCOUNTING POLlCtES - continued
Expenditure
Grants payablc are charged in the year when ihc offer 15 madc cxcepi in thosc ca5cs where the offer is conditional, such grants
being recogniscd as cxpcnditurc when the condition5 attaching arc fulfillcd.
Grants offered subject to conditions which have not iKen met at thc year end date are noted as a commitment but not accrued
as eApenditurc.
Tangible fixed assets
All assets costing more than £21K) are capiialised.
Depreciaiion is provided at ihe following annual raies in order to write off each assei over its esiimaied useful life.
Leasehold property
Fixtures and fittings
Computer equipment
- Over 20 vears
- Over 4 years
- Over 4 years
Stock5
Stocks are valued at the lower of cost and net realisable value. after making due allowance for obsolete and slow moving
iiems.
Cosi includes all direci costs and an appropriatr prow)rtion or rixed and variable overheads.
Taxation
The charity is exempt from corporniion thx on irs chariiable aciiviiies offered by Ihe Cortx)rntion Tax Act Part 2 of chapier 3.
Accordingly there is no corwration charge in these accounts.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Rcstrictcd funds can only bc used for particular re5trictcd purwjses within thc objccts of the charity. Restrictions arise when
specified by the donor or when funds are raised for particular restricted purpises.
Further explanatson of the nature and purpose of each fund is included in thc notcs to the financial statcmentS.
Operating leases
Renial% under operaiing leases are chorged io the Sthiemeni of financial aciivities Incor￿raIlng income and expendiiure
accouni on a straighi line basis over the lease temi.
Pension costs gnd other post-retirement benefits
The ¢hariLqble company operdtrs a defined contribuiion pension scheme. Contribuiions payable io the charitable company's
pension scheme are charged 10 the S[￿ement of Financial Aciivities in the ￿ri(KI io which they relate.
Company statu5
The company is a company limiied by ouaraniee. The members of the company are the Truqiees named on page l. In the event
of the company being wound up. the liability in respeci of the guarantee is litnited to £1 member of the company.
Interes¢ receivable
Page 17
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
ACCOUNTING POLlCtES - continued
Company statu5
Interest on funds held on dcposit is includcd when rcccivablc and the aJnounl can k mcasurcd reliably by the company; this is
normally upon notification of thc inlercsl paid or payable by the Bank.
Debtors
Trade and oiher debiors are recognised at the setilemeni amouni af￿r any trade discouni offered. Prepaymenis are valued ai ihe
amouni prepaid nei of any trade discounts due.
Cash at Bank in hand
Cash at bank in hand includes cash and short ienn highly liquid invesunenis with a short maturiiy of Ihree monihs or less from
the date of acquisition or opening of the dewsit or similar accouni.
Cash deposits that are not readily accessible within 3 months are classified as Term deposits.
Liabilities and proTrisions
Liabilities are recognised when there is an obligation ai the Balance sheet dale &s a resul( of a p&si eveni. il is probable ihai a
rransfer of economic benefi¢ w'ill k required in setilemeni. and the amouni of ihe %eiilemeni can be esiimaied reliably.
Liabilities are recognised ai the amouni thai the company antscipatrd il will pay io seiile the debi or ihe amount it h&$ received
as advanced paymenis for ihe goods or services il musi provide.
Financial instruments
The company only has financial &sseis and financial liabiliiies of a kind thai qualify as b&sic financial instn]ments. Basic
financial instruments are iniiially recogni.sed at rransaciion value and subsequenily measured ai their settlement value with the
exception of bank loans which are subsequently measured at amortised cost using the effective inieresl method.
DONATIONS AND LEGACIES
2023
2022
Donations
Legacies
315,992
5(19
228,178
490,613
825J32
718.791
Page 18
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
OTHER TRADING ACTIvrfiES
2023
2022
Fundraising events
Other incoming rcsouiccs
Trading
26,574
3,770
871
4,028
31,044
35,943
INVESTMENT INCOME
2023
2022
Investtnent income
49,640
12.735
INCOME FROM CHAIUTABLE ACTIV￿[￿5
2023
2022
Activity
Infortnation and Support
Subscriptions
93,051
CHAIUTABLE ACTIVITIES COSTS
Grant
funding of
aciii'ilies
{scc notc 8)
Dirccl
Costs
(sec notr 7)
Support
(see notc 9)
Totals
Fundraising Ex￿nSeS
Inforn)ation and Support
9,8&1
61MI,939
9,884
743,726
137,654
5,133
610,823
137,654
5,133
753,610
Page 19
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
DIRECT COSTS OF CHARrrABLE ACTtvrrIES
2023
2022
Statf costs
Equipment hire
Purchases
Postagc, tclcphonc and stationery
Sundries
Travel and subsisience
Meeting cosis
Printing
Office expenses
Repair8 and mainienance
Cleaning
rr Costs
Irrecoverable VAT
Subscriptions
Training
Magazine contractors
Medical literature
Fundraising Cosi
Other ¢osis
websi￿ Costs
Creative Costs
Campaigns
Depreciation
Interest payable and similar charges
344,999
940
6,707
31,726
I￿00
1032
94
39,057
10,222
310
1,067
11,497
10,217
5,161
361
306,fQl
,955
5,020
34,726
,820
1,-525
8.31
37,139
6.526
3.902
997
6.874
10.588
3.635
898
25.3¢X)
40.837
3,738
9084
3053
1,213
1.985
7J81
75,235
12,006
4,196
11,434
4.493
610023
524.449
GRANTS PAY ABLE
2023
2022
Research - Bio bank
Research - Evidence B&%ed Rehabiliiaiion Academy
Research - University of Leice51erl Liverpool
Research - London Sch￿] of Hygiene
90.165
43,514
7,102
11,441
137,654
101,606
Pagc 20
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
SUPPORT COSTS
Governance
costs
Information and Support
Support costs, included in the above, arc as follows..
2023
2022
Inforniation
and
Support
Total
actsvitiCS
ACcoUn￿nCY fees
5,133
iJ46
io.
NET INCOMFJ(EXPENDITURE)
Ner in¢omellexpendiiure) is sthted afier chargingl(crediling)=
2023
2022
Accountancy fees
Depreciation - owned assets
Equipment hire
5,133
12,007
940
5.346
11.433
.955
ii.
TRUSTEES, REMUNERATION AND BENEFITS
There were no trustees, remuneration or other benefits for the year ended 31 December2023 nor for the year ended
31 tkccmber 2022.
Trust(*s' expenses
During ¢urreni year four TNstees received reimlwrsemeni ofexpenses amouniing 10 £6,254, {2022- 4 Trusiee - £3,088).
Page21
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
12.
STAFF COSTS
2023
2022
Wages and salaries
Social security COSts
Other pension costs
322,460
15,685
284.510
1.S,866
6,?25
306,601
The average monthly number of employees during the year was as follows..
2023
13
2022
12
Average Employees
No employees received emoluments in excess of £60.IM)O.
The Key Managemcnt Pcr50nncl of thc charity arc rcprcscntcd by thc trustces, who arc not rcmunerated.
13.
COMPARA TIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - 2022
Unrestricted
fund
Restricted
fund
Total
funds
INCOTrIE AND ENDOWMENTS FROM
Donaiions and legacies
672,190
46,601
718,791
Charitable actiTrities
Infomiation and Support
93.051
93,051
Other trading activities
Investtnent income
35.943
9.732
35,943
12.735
3,003
Total
810,916
49,604
860,520
EXPENDrruRE ON
Charitable activities
Infom)aiion and Support
526.9)4
104,407
631,401
NET ￿CoMFJ{EXpENDrrURE)
Transfers between funds
283.922
1367)
154,8031
229,119
Net movement in funds
283.555
154,436)
229,119
RECONCILIATION OF FUNDS
Toial funds bioughi forward
2,335.719
779,737
3,115,456
Pagc 22
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
13.
COMPARATIVES FOR THE sTATE￿￿￿T OF FINANCIAL ACTIVITtES - 2022 . continued
Unrestricted
Restricted
fund
fund
Total
funds
TOTAL FUNDS CARRIED FORWARD
2.619,274
725,301
3,344,575
14.
TANGIBLE FIXED ASSETS
Fixtures
t£asehold
property
Computer
equipment
fittings
Totals
COST
At l January 2023
Additions
Disposals
177,712
2,482
12,980
2,090
(W3)
193.174
2,090
(9931
At 31 December 2023
177,712
2A82
14,077
194,271
DEPRECIATION
Ai l January 2023
Charoe for year
Eliminated on disposal
6221M)
8,886
1014
498
6,489
2,623
(993)
70,503
12,007
(993)
At.31 December 202.3
71,086
2J12
8,119
NET BOOK VALUE
At 31 December 2023
106.626
170
112,754
At 31 December 2022
115.512
668
6,491
122,671
15.
STOCKS
2023
2022
Siocks
8571
10.986
Page 23
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
16.
DEB TORS: AMOUNTS FALLING DUE ￿TH[N ONE YEAR
2023
2022
Trade debtors
Other debtors
Tax recoverable
Lcgacics
Prcpaymcnts and accrued income
114
8,558
2,151
390.WM)
1,721
797.51K)
403520
806.091
17.
CURRENT ASSET INVESTMENTS
2023
2022
Term dcposit5
2 006 445
1.061,717
18.
CREDITORS: AMOUNTS FALLING DUE WllTH￿ ONE YEAR
2023
2022
Trade creditors
Social 8e¢urity and other taxes
Other creditors
Grant commiiments
Accruals and deferred income
5053
5,183
37,221
21,757
47,550
7,749
5,270
40,874
117564
97,445
Deferred Income
DefeTrcd Income at l January 2023
Resources deferred duting (he year
Amounts released from previous years
38,952
37,860
138,952}
Deferred Income at 31 December 2023
37,860
Dcfcrrcd incoTllC represents defcrrcd annual mcmbership 5ubscription5.
Pagc 24
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
19.
MOVEMENT IN FUNDS
Net
movement
in fund5
Transfers
beiween
funds
At
31.12.23
At 1.1.23
Unrestrieted funds
General Fund - Unrestrictcd
Designated Fund- Sinking Fund
Designaied Fund - Core Services
2,619274
211,654
(495S(M)I
5.000
4WS00
2,335,428
5,000
4905(KI
1619,274
211,654
2,830,928
Restricted funds
Ramsay Research Fund
725JOI
52581
777,882
TOTAL FUNDS
3314.575
264.235
3,608,810
Net movement in funds. included in the above are as follows=
IncoTniTtg
rc50urce5
Rcsourccs
cxpended
Movement
in funds
Unrestricted funds
General Fund - Unrestrictrd
827,610
(615,9561
211,654
Restricted funds
Ramsay Research Fund
190235
{137,654)
52,581
TOTAL FUNDS
1,017,IM5
(753,610)
264,235
Pagc 25
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
19.
MOVEMENT IN FUNDS - eontinlled
Comparatives for movement in fun(L
Nct
Tnoi'cmcnt
in fund5
Transfers
between
funds
At
31.12.22
At 1.1.22
Unrestricted funds
General Fund - Unrestrictrd
2,3.15.719
283.922
1367)
2,619,274
Restricted funds
Ramsay Research Fund
779.737
(54.8031
367
725,301
TOTAL FUNDS
3.115.456
229,119
3,344.575
Comparative net movement in funds. included in the alKJVC arc as follows=
Incoming
resources
Resour¢es
expended
Movemeni
in funds
Unrestricted funds
General Fund - Unrestricied
810.916
(526,9941
283,922
Restricted funds
Ramsay Research Fut]d
49.604
(104,407)
{54.8031
TOTAL FUNDS
860,520
(631,401}
229,119
Pagc 26
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
19.
MOVEMENT IN FUNDS - eontinlled
A current year 12 months and prior year 12 months combined position is as follows..
Nct
Tnoi'cmcnt
in fund5
Transfers
between
funds
At
31.12.23
At 1.1.22
Unrestricted funds
General Fund - Unrestrictrd
Designaied Fund- Sinking Fund
Designaied Fund- Core Services
2,3.15.719
495.576
(495,867)
5,000
490,500
2,33.5,428
5,000
490,500
2,-135.719
495,576
1367)
2,880,928
Restricted funds
Ramsay Research Fund
779.737
(2.222)
367
777,882
TOTAL FUNDS
3.115.456
493.354
3.608,810
A currcnt ycar 12 month5 and prior year 12 months combined nct Tnovemcnt in funds, included in the above arc as follows..
Incoming
resources
Resources
expended
Movement
in fund.s
Unrestricted funds
General Fund - Unrestricted
1.638.526
(1.142.950}
495,576
Restricted funds
Ramsay Research Fund
239.839
(242,061)
(2,222}
TOTAL FUNDS
1,878.365
11..385,011)
498,-3.54
Ramsay Re.sear¢h This fund reflecis funding resirictrd for use iowards medical and scieniific research inio the naiure and
function of the disease processes involvcd in ME, plu5 CFS & PVFS a5 appropriatc, and into the development of potential
treaimenis for Such aspecis of the disease.
Page 27
continucd...

THE MYALGIC ENCEPHALOPATHY ASSOCIATION LIMITED
NOTES TO THE FINANCIAL STATEMENTS- continued
FOR THE YEAR ENDED 31 DECENIBER 21)23
20.
RELATED PARTY DISCLOSURES
Within the year Constellation IX Limited. a company that David Allen is both a direclor and shareholder of. invoiced the
charity £8,948 (2022= £11.810) {inc. V ATI in re5PCCt of IT support. equipTnent and sundry supplie5.
Within thc year Ainsworth & Wells Limited. a company that Martinc Ainsworth-wells is both a director and shareholder of,
invoiced the charity £31,2W (2022= £16.81M)) linc. V ATI in rcspcct of campaign work.
All transaciions were undertaken ai ams, length.
Pagc 28